Eletriptan, sold under the brand name Relpax and used in the form of eletriptan hydrobromide, is a second-generation triptan medication intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer.
{{Drugbox | Verifiedfields = verified | Watchedfields = verified | verifiedrevid = 459434734 | image = Eletriptan skeletal.svg | width = 250px | image_class = skin-invert-image | image2 = Eletriptan 3D ball-and-stick.png | image_class2 = bg-transparent | width2 = 250px
| tradename = Relpax, others | Drugs.com = | MedlinePlus = a603029 | DailyMedID = Eletriptan | pregnancy_AU = B1 | routes_of_administration = By mouth | class = Serotonin 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F receptor agonist; Triptan; Antimigraine agent | ATC_prefix = N02 | ATC_suffix = CC06 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).